Avotres Inc.
PrivateLast Round
Series A
Feb 24, 2021
Total Funding Raised
$4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Avotres Inc. is a biotechnology company that develops novel immune-regulating therapies for autoimmune diseases, cancers, and transplantation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avotres Inc. Comparables
Compare Avotres Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mozart Therapeutics | 88% | |
| GentiBio | 84% | |
| Tr1X | 84% | |
Avotres Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 24, 2021 |
Avotres Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Photon Fund | Series A |
| Foothill Ventures | Series A |
| Proxima Ventures Ltd. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors grew 96% MoM.
- Jun 1, 2025
Monthly visitors grew 212% MoM, reaching 1.3K.
Avotres Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avotres Inc.'s valuation, stock price, and market status.